Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Jill Ford"'
Autor:
Jill Ford, Angela Hughson, Kihong Lim, Susana V. Bardina, Wuyuan Lu, Israel F. Charo, Jean K. Lim, Deborah J. Fowell
Publikováno v:
Frontiers in Immunology, Vol 9 (2019)
The chemokine CCL7 (MCP3) is known to promote the recruitment of many innate immune cell types including monocytes and neutrophils to sites of bacterial and viral infection and eosinophils and basophils to sites of allergic inflammation. CCL7 upregul
Externí odkaz:
https://doaj.org/article/4a19ab8d9dc9495a98fb91b1e274de4c
Autor:
Christopher A Lazarski, Jill Ford, Shoshana D Katzman, Alexander F Rosenberg, Deborah J Fowell
Publikováno v:
PLoS ONE, Vol 8, Iss 8, p e71949 (2013)
Interleukin 4 (IL-4) plays a central role in the orchestration of Type 2 immunity. During T cell activation in the lymph node, IL-4 promotes Th2 differentiation and inhibits Th1 generation. In the inflamed tissue, IL-4 signals promote innate and adap
Externí odkaz:
https://doaj.org/article/3908e5c6bf184c89b269eeaa1237b677
Autor:
Jill Ford, Vivian Chiu
Publikováno v:
Arts Across Cultures ISBN: 9781506497471
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6d2bd22dd1c25a0a338137f00d12f297
https://doi.org/10.2307/jj.1640515.8
https://doi.org/10.2307/jj.1640515.8
Autor:
Shane Sheredy, Mollie E. Moran, Jennifer A. Woyach, Jill Ford, Emily Desmond, Kristin Lynn Koenig, John C. Byrd, Emily Dotson, Seema A. Bhat, Shauna Iarocci, Margaret S. Lucas, Kerry A. Rogers, Ying Huang, Tracy Wiczer, Jeffrey A. Jones, Farrukh T. Awan
Publikováno v:
Blood Adv
Venetoclax has efficacy in patients relapsing after B-cell receptor pathway inhibitors (BCRis); however, because of the risk of tumor lysis syndrome (TLS), a 5-week dose ramp-up is required to attain the target dose. Patients relapsing after BCRis fr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5e7a766200579fcd16dd74b31f4d703
https://pubmed.ncbi.nlm.nih.gov/33031541
https://pubmed.ncbi.nlm.nih.gov/33031541
Autor:
Jean K. Lim, Kihong Lim, Deborah J. Fowell, Susana V. Bardina, Israel F. Charo, Jill Ford, Wuyuan Lu, Angela Hughson
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 9 (2019)
Frontiers in Immunology, Vol 9 (2019)
The chemokine CCL7 (MCP3) is known to promote the recruitment of many innate immune cell types including monocytes and neutrophils to sites of bacterial and viral infection and eosinophils and basophils to sites of allergic inflammation. CCL7 upregul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::239c1d0095fb7414be7a8cb446a1d508
https://doi.org/10.3389/fimmu.2018.03063
https://doi.org/10.3389/fimmu.2018.03063
Autor:
Jill Ford, Alison C. Billroth-MacLurg, Deborah J. Fowell, Alexander F. Rosenberg, James H. Miller
Publikováno v:
The Journal of Immunology. 197:2208-2218
CD4+Foxp3+ regulatory T cells (Tregs) are key immune suppressors that regulate immunity in diverse tissues. The tissue and/or inflammatory signals that influence the magnitude of the Treg response remain unclear. To define signals that promote Treg a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::430b772fa8577fe007e5b696f337c6c2
https://doi.org/10.4049/jimmunol.1502575
https://doi.org/10.4049/jimmunol.1502575
Autor:
Jill Ford
Originally published in 1983, this clear-sighted study built an understanding of what human behaviour meant at the time: an understanding which can still be of practical use for those who work with people in their everyday lives today.The various inf
Autor:
Jean-Pierre Max, Nacira Sennoun, Sébastien Gibot, Frédéric Massin, Bruno Levy, Valance Washington, Youcef Bouazza, Marc Derive, Jill Ford, Corentine Alauzet, Daniel W. McVicar, Laura Quigley, Sandra Marchionni
Publikováno v:
The Journal of Immunology. 188:5585-5592
The triggering receptor expressed on myeloid cells (TREM)-1 plays a crucial role during the onset of sepsis by amplifying the host immune response. The TREM-like transcript-1 (TLT-1) belongs to the TREM family, is selectively expressed on activated p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47d725d5467b03982f461b598984161f
https://doi.org/10.4049/jimmunol.1102674
https://doi.org/10.4049/jimmunol.1102674
Autor:
Anthony Dellinger, Peggy Scherle, David R. Gibb, Andrew Q. Ford, Achsah D. Keegan, Christopher L. Kepley, Sarah K. Norton, Jill Ford, Joel A. Mathews, Daniel H. Conrad, Dae-Joong Kang, Hugh Massay
Publikováno v:
Allergy. 66:1193-1200
Background: Elevated levels of CD23, a natural regulator of IgE production, have been shown to decrease the signs of lung inflammation in mice. The aim of this study was to study the involvement of ADAM10, the primary CD23 sheddase, in experimental a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::10fe6f6eabb94dd7955d9c18ae8e907f
https://doi.org/10.1111/j.1398-9995.2011.02614.x
https://doi.org/10.1111/j.1398-9995.2011.02614.x
Autor:
Geraldine M. O’Connor, Daniel W. McVicar, Jill Ford, Stephen Roessler, Timothy A. Chan, Laura Quigley, Selinda J. Orr
Publikováno v:
The Journal of Immunology. 185:1393-1403
X-linked SCID patients are deficient in functional IL-2Rgamma(c) leading to the loss of IL-2/IL-4/IL-7/IL-9/IL-15/IL-21 signaling and a lack of NK and mature T cells. Patients treated with IL-2Rgamma(c) gene therapy have T cells develop; however, the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f6b87422ca93f9dc45ca912d746a2d6
https://doi.org/10.4049/jimmunol.0903528
https://doi.org/10.4049/jimmunol.0903528